Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes

Journal of Virological Methods

Volumn 170, Issue 1-2, 2010, Pages 115-120

  Li, Peilin ^a,b   Ruel, Theodore ^a   Fujimoto, Katsuya ^a,b   Hatano, Hiroyu ^a,c   Yukl, Steven ^a,b   Eller, Leigh Anne ^d   Liegler, Teri ^a   Kamya, Moses ^d   Gassasira, Anne ^d   Dorsey, Grant ^a,c   Rosenthal, Philip J ^a,c   Havlir, Diane V ^a,c   Wong, Joseph K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d MAKERERE UNIVERSITY   (Uganda)

Author keywords

Dried blood spots; HIV; HIV subtypes; Locked Nucleic Acid; Taqman PCR

Indexed keywords

LOCKED NUCLEIC ACID; VIRUS DNA; VIRUS RNA;

ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA PROBE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA PROBE; SEQUENCE ANALYSIS; UGANDA; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

CHILD; DNA, VIRAL; GENETIC HETEROGENEITY; HIV INFECTIONS; HIV-1; HUMANS; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UGANDA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78249264742     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.09.011     Document Type: Article

References (41)

1. Althaus C.F., Gianella S., Rieder P., von Wyl V., Kouyos R.D., Niederost B., Schmid A., Metzner K.J., Joos B., Gunthard H.F., Fischer M. Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance. J. Virol. Methods 2010, 165:151-160.
2. Buckton A.J., Bissett S.L., Myers R.E., Beddows S., Edwards S., Cane P.A., Pillay D. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J. Antimicrob. Chemother. 2008, 62:1191-1198.
3. Cachafeiro A., Sherman G.G., Sohn A.H., Beck-Sague C., Fiscus S.A. Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. J. Clin. Microbiol. 2009, 47:459-462.
4. Creek T.L., Sherman G.G., Nkengasong J., Lu L., Finkbeiner T., Fowler M.G., Rivadeneira E., Shaffer N. Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences. Am. J. Obstet. Gynecol. 2007, 197:S64-71.
5. Debiaggi M., Zara F., Pistorio A., Bruno R., Sacchi P., Patruno S.F., Achilli G., Romero E., Filice G. Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy. Int. J. Infect. Dis. 2000, 4:187-193.
6. Desire N., Dehee A., Schneider V., Jacomet C., Goujon C., Girard P.M., Rozenbaum W., Nicolas J.C. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol. 2001, 39:1303-1310.
7. Drosten C., Seifried E., Roth W.K. TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J. Clin. Microbiol. 2001, 39:4302-4308.
8. Folks T.M., Powell D., Lightfoote M., Koenig S., Fauci A.S., Benn S., Rabson A., Daugherty D., Gendelman H.E., Hoggan M.D. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J. Exp. Med. 1986, 164:280-290.
9. Gardner S.N., Kuczmarski T.A., Vitalis E.A., Slezak T.R. Limitations of TaqMan PCR for detecting divergent viral pathogens illustrated by hepatitis A, B, C, and E viruses and human immunodeficiency virus. J. Clin. Microbiol. 2003, 41:2417-2427.
10. Geelen S., Lange J., Borleffs J., Wolfs T., Weersink A., Schuurman R. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission. AIDS 2003, 17:781-782.
11. Gottlieb G.S., Sow P.S., Hawes S.E., Ndoye I., Redman M., Coll-Seck A.M., Faye-Niang M.A., Diop A., Kuypers J.M., Critchlow C.W., Respess R., Mullins J.I., Kiviat N.B. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J. Infect. Dis. 2002, 185:905-914.
12. Higuchi R., Dollinger G., Walsh P.S., Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology (N Y) 1992, 10:413-417.
13. Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) 1993, 11:1026-1030.
14. Holland P.M., Abramson R.D., Watson R., Gelfand D.H. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. U.S.A 1991, 88:7276-7280.
15. Ikomey G.M., Atashili J., Okomo-Assoumou M.C., Mesembe M., Ndumbe P.M. Dried blood spots versus plasma for the quantification of HIV-1 RNA using the manual (PCR-ELISA) Amplicor Monitor HIV-1 Version 1.5 Assay in Yaounde, Cameroon. J. Int. Assoc. Physicians AIDS Care (Chic Ill) 2009.
16. Kamat A., Ravi V., Desai A., Satishchandra P., Satish K.S., Borodowsky I., Subbakrishna D.K., Kumar M. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay. J. Clin. Virol. 2007, 39:9-15.
17. Kerr R.J., Player G., Fiscus S.A., Nelson J.A. Qualitative human immunodeficiency virus RNA analysis of dried blood spots for diagnosis of infections in infants. J. Clin. Microbiol. 2009, 47:220-222.
18. Kostrikis L.G., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Karafoulidou A., Goedert J.J., Hatzakis A. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J. Virol. 2002, 76:10099-10108.
19. Kumar R., Singh S.K., Koshkin A.A., Rajwanshi V.K., Meldgaard M., Wengel J. The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2'-thio-LNA. Bioorg. Med. Chem. Lett. 1998, 8:2219-2222.
20. Latorra D., Campbell K., Wolter A., Hurley J.M. Enhanced allele-specific PCR discrimination in SNP genotyping using 3' locked nucleic acid (LNA) primers. Hum. Mutat. 2003, 22:79-85.
21. Leelawiwat W., Young N.L., Chaowanachan T., Ou C.Y., Culnane M., Vanprapa N., Waranawat N., Wasinrapee P., Mock P.A., Tappero J., McNicholl J.M. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J. Virol. Methods 2009, 155:109-117.
22. Luo W., Yang H., Rathbun K., Pau C.P., Ou C.Y. Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. J. Clin. Microbiol. 2005, 43:1851-1857.
23. Mellors J.W., Rinaldo C.R., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
24. Montoya J.G., Wood R., Katzenstein D., Holodny M., Merigan T.C. Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect. J. Clin. Microbiol. 1993, 31:2692-2696.
25. Morandi L., Ferrari D., Lombardo C., Pession A., Tallini G. Monitoring HCV RNA viral load by locked nucleic acid molecular beacons real time PCR. J. Virol. Methods 2007, 140:148-154.
26. Mouritzen P., Nielsen A.T., Pfundheller H.M., Choleva Y., Kongsbak L., Moller S. Single nucleotide polymorphism genotyping using locked nucleic acid (LNA). Expert Rev. Mol. Diagn. 2003, 3:27-38.
27. Osmanov S., Pattou C., Walker N., Schwardlander B., Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J. Acquir. Immune Defic. Syndr. 2002, 29:184-190.
28. Ou C.Y., Yang H., Balinandi S., Sawadogo S., Shanmugam V., Tih P.M., Adje-Toure C., Tancho S., Ya L.K., Bulterys M., Downing R., Nkengasong J.N. Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. J. Virol. Methods 2007, 144:109-114.
29. Palmer S., Wiegand A.P., Maldarelli F., Bazmi H., Mican J.M., Polis M., Dewar R.L., Planta A., Liu S., Metcalf J.A., Mellors J.W., Coffin J.M. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 2003, 41:4531-4536.
30. Peeters M., Sharp P.M. Genetic diversity of HIV-1: the moving target. AIDS 2000, 14(Suppl. 3):S129-S140.
31. Peter Mouritzen M.N., Nielsen P.S., Jacobsen N., Lomholt C., Pfundheller H.M., Tolstrup N. ProbeLibrary: a new method for faster design and execution of quantitative real-time PCR. Nat. Methods 2005, 2:3.
32. Rouet F., Chaix M.L., Nerrienet E., Ngo-Giang-Huong N., Plantier J.C., Burgard M., Peeters M., Damond F., Ekouevi D.K., Msellati P., Ferradini L., Rukobo S., Marechal V., Schvachsa N., Wakrim L., Rafalimanana C., Rakotoambinina B., Viard J.P., Seigneurin J.M., Rouzioux C. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J. Acquir. Immune Defic. Syndr. 2007, 45:380-388.
33. Sherman G.G., Stevens G., Jones S.A., Horsfield P., Stevens W.S. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J. Acquir. Immune Defic. Syndr. 2005, 38:615-617.
34. Simeonov A., Nikiforov T.T. Single nucleotide polymorphism genotyping using short, fluorescently labeled locked nucleic acid (LNA) probes and fluorescence polarization detection. Nucleic Acids Res. 2002, 30:e91.
35. Suwannakarn K., Payungporn S., Chieochansin T., Samransamruajkit R., Amonsin A., Songserm T., Chaisingh A., Chamnanpood P., Chutinimitkul S., Theamboonlers A., Poovorawan Y. Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J. Virol. Methods 2008, 152:25-31.
36. Swanson P., de Mendoza C., Joshi Y., Golden A., Hodinka R.L., Soriano V., Devare S.G., Hackett J. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3. 0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 2005, 43:3860-3868.
37. Tang N., Huang S., Salituro J., Mak W.B., Cloherty G., Johanson J., Li Y.H., Schneider G., Robinson J., Hackett J., Swanson P., Abravaya K. A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples. J. Virol. Methods 2007, 146:236-245.
38. Uttayamakul S., Likanonsakul S., Sunthornkachit R., Kuntiranont K., Louisirirotchanakul S., Chaovavanich A., Thiamchai V., Tanprasertsuk S., Sutthent R. Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection. J. Virol. Methods 2005, 128:128-134.
39. Valasek M.A., Repa J.J. The power of real-time PCR. Adv. Physiol. Educ. 2005, 29:151-159.
40. You Y., Moreira B.G., Behlke M.A., Owczarzy R. Design of LNA probes that improve mismatch discrimination. Nucleic Acids Res. 2006, 34:e60.
41. Zhao Y., Yu M., Miller J.W., Chen M., Bremer E.G., Kabat W., Yogev R. Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology. J. Clin. Microbiol. 2002, 40:675-678.